26th Mar 2014 10:53
LONDON (Alliance News) - Oxford Pharmascience Group PLC Wednesday said Non-Executive Chairman David Norwood bought 1 million shares at a price of 4.3 pence per share Tuesday.
Following this transaction, Norwood now holds 106 million shares, which represents 10.62% stake in the firm.
Shares in the specialist pharmaceutical technology company were trading up 10% at 4.85 pence Wednesday morning.
By Arvind Bhunjun; [email protected]; @ArvindBhunjun
Copyright © 2014 Alliance News Limited. All Rights Reserved.
Related Shares:
Oxford Pharmascience Group